PROTAGONIST THERAPEUTICS Trademark

Trademark Overview


On Wednesday, February 28, 2018, a trademark application was filed for PROTAGONIST THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the PROTAGONIST THERAPEUTICS trademark a serial number of 87814966. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, August 7, 2019. This trademark is owned by Protagonist, Inc.. The PROTAGONIST THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research, pharmaceutical research, medical research; technical and scientific consultation and product development services, including for others, in the fields of immune mediated diseases, inflammatory diseases, and rare diseases; research and development of new products pertaining to the treatment of immune mediated diseases, inflammatory diseases, and rare diseases, and to pharmaceuticals; providing on line information for medical research purposes, in the fields of immune mediated diseases, inflammatory diseases, and rare diseases, treatments for immune mediated diseases, inflammatory diseases, and rare diseases, and pharmaceuticals
protagonist therapeutics

General Information


Serial Number87814966
Word MarkPROTAGONIST THERAPEUTICS
Filing DateWednesday, February 28, 2018
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, August 7, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesScientific research, pharmaceutical research, medical research; technical and scientific consultation and product development services, including for others, in the fields of immune mediated diseases, inflammatory diseases, and rare diseases; research and development of new products pertaining to the treatment of immune mediated diseases, inflammatory diseases, and rare diseases, and to pharmaceuticals; providing on line information for medical research purposes, in the fields of immune mediated diseases, inflammatory diseases, and rare diseases, treatments for immune mediated diseases, inflammatory diseases, and rare diseases, and pharmaceuticals

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 7, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameProtagonist, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewark, CA 94560

Trademark Events


Event DateEvent Description
Wednesday, August 7, 2019ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, August 7, 2019ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, January 9, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 9, 2019NON-FINAL ACTION E-MAILED
Wednesday, January 9, 2019NON-FINAL ACTION WRITTEN
Saturday, December 15, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 14, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 14, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 15, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 15, 2018NON-FINAL ACTION E-MAILED
Friday, June 15, 2018NON-FINAL ACTION WRITTEN
Tuesday, June 12, 2018ASSIGNED TO EXAMINER
Wednesday, March 7, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, March 3, 2018NEW APPLICATION ENTERED IN TRAM